with Sanofi

Sanofi confronted plateauing Dupixent growth as clinical success met behavioural, perceptual, and operational barriers across the healthcare ecosystem. Strativity, a UST company, ran a six‑phase, human‑centred innovation program—Discover, Understand, Co‑Create, Test & Iterate, Prioritise, Plan—combining 100+ stakeholder interviews, behavioural research, and ecosystem analysis. The effort produced 28 high‑value insights, 389 idea submissions distilled to 16 concepts, and 10 customer‑validated solutions, with six ready for implementation and an enterprise roadmap to scale execution, improve patient and provider experience, and drive adoption.